查詢結果分析
來源資料
相關文獻
- Leiomyosarcoma of the Prostate in Adults: A Case Report
- 頰黏膜平滑肌肉瘤--病例報告
- Factors Related to Delayed Treatment and Posttreatment Symptom Severity in Taiwanese Patients with Benign Prostatic Hyperplasia
- Morbidity with Contemporary Transrectal Biopsy of the Prostate
- 良性前列腺肥大之治療
- 臺灣地區之前列腺癌
- Flow Cytometric Measurement of Proliferation Rate in Human Hyperplastic Serum Psa Level, Cellular Component, Prostate Volume and Regrowth Rate
- The Role of Percent Free-Prostate Specific Antigen (PSA) in Patients with Total PSA Levels between 4.0 and 10.0 ng/ml
- Eosinophilic Cystitis and Ureteritis after Radical Prostatectomy: Case Report and Literature Review
- 神經纖維瘤病合併空腸平滑肌肉瘤及消化道出血:病例報告
頁籤選單縮合
題 名 | Leiomyosarcoma of the Prostate in Adults: A Case Report=成人前列腺平滑肌肉瘤 |
---|---|
作 者 | 李偉華; 于大雄; 張聖原; | 書刊名 | 醫學研究 |
卷 期 | 20:2 1999.10[民88.10] |
頁 次 | 頁78-83 |
分類號 | 416.275 |
關鍵詞 | 平滑肌肉瘤; 前列腺; 免疫組織化學染色; 流動細胞儀; Ki-67增殖指數; Leiomyosarcoma; LMS; Prostate; Immunohistochemistry; Flow cytometry; Ki-67 proliferative index; |
語 文 | 英文(English) |
中文摘要 | 成人前列腺平滑肌肉瘤為罕見腫瘤,約佔所有前列腺惡性腫瘤的0.1%。直到目前,僅有少於 100 例的報告。我們報告一位 78 歲男性罹患罕見高惡性度平滑肌肉瘤。 該病人以良性前列腺增生為其初期臨床表現症狀。再接受經尿道前列腺切除術後二個月左右,因多發性肺臟及肝臟遠端轉移而死亡。 組織病理檢查發現惡性腫瘤細胞對 vimentin, actin與 desmin 呈陽性免疫染色反應。Ki- 67 的增殖指數為 65%。 以流動細胞儀檢查發現惡性腫瘤細胞屬異套核型。我們認為當成年男性罹患良性前列腺增生必須將前列腺平滑肌肉瘤列入重要鑑別診斷。 |
英文摘要 | Leiomyosarcoma(LMS) of the prostate in adults is a rare neoplasm that accounts for less than 0.1¢H of prostate malignancies. To date, less than 100 cases have been reported. We reported a rare case of high grade LMS in a 78-year-old man who presented initial clinical picture as benign prostate hyperplasia(BPH). He developed multiple, distant metastases of the lungs and liver and expired, post-TURP treatment 2 months later. Histopathological examinations of maligerative labeling index was 65¢H. The flow cytometry examination of malignant tumor cells revealed an aneuploid status. LMS of the prostate in adults should be considered in an important differential diagnosis for BPH patients. |
本系統中英文摘要資訊取自各篇刊載內容。